Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy, have ...

When prescribing glucagon-like peptide 1 (GLP-1) medications, many physicians prefer tirzepatide over the more well-known semaglutide due to its superior efficacy in weight loss and A1c reduction.

The head of the company that makes the diabetes and obesity drugs Ozempic and Wegovy has warned that compounded versions of ...

The FDA became aware of the problem after a patient submitted a complaint to the regulator that a vial of semaglutide from ...

Diabetes drug tirzepatide has been shown to help people lose almost 16% of their body weight in a clinical trial, and it could soon join semaglutide and liraglutide in the ranks of buzzy weight ...

When starting prescription weight loss medications, getting approval from a doctor and insurance is one of the hardest parts.

Results from a retrospective cohort study show lower all-cause mortality and fewer hospitalizations and intestinal ...

There's buzz around certain type 2 diabetes drugs, which not only help regulate blood sugar but can also lead to significant ...

The diabetes and weight loss medications Ozempic and Wegovy are now considered to be available after more than two years ...